In this seminar, Diane Hamlin, Eli Lilly and Company, presents Performance of the Gyrolab xP System for Custom Development of Preclinical Urinary Renal Biomarker Assays at the International Gyrolab Seminar, ‘Changing the Immunoassay Landscape using Automated Nanoliter-scale Innovation’ in Morristown, NJ, USA.

In this presentation, Diane showed that using the Gyrolab platform:

  • Custom immunoassays were rapidly developed & validated 
  • Sample analysis had short “hands-on” time and reduced total elapsed time
  • For urinary KIM1 and NGAL, the method provided equivalent or improved quantitation range compared to the ECL assay
  • Gyrolab methods were robust across multiple reagent preparations and different CD lots